Trial Profile
Long-term Effect of Chronic Ibrutinib Therapy on Left Atrial Function
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2023
Price :
$35
*
At a glance
- Drugs Ibrutinib (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- Acronyms CITE-LA
- 13 Oct 2023 Status changed from recruiting to completed.
- 17 Dec 2018 Status changed from not yet recruiting to recruiting.
- 30 Nov 2018 New trial record